Mesoblast LTD

James Michael O'Brien, Chief Financial Officer of Mesoblast Ltd., was granted 650,000 stock options with an exercise price of AUD 2.90.

George Gregory, a Director and 10% owner of Mesoblast Ltd, reported the acquisition of over 3 million ordinary shares across multiple transactions in early April 2026.

George Gregory, a Director and 10% owner of Mesoblast Ltd, has reported the acquisition of a significant number of ordinary shares through multiple transactions.

Dr. William J. Gueck has reported a 5% beneficial ownership stake in Mesoblast Ltd., primarily through shared voting and dispositive power over various trusts and holding companies.

Gregory George and related entities have significantly increased their beneficial ownership in Mesoblast Limited, now holding 21.59% of the company's ordinary shares.